Nasdaq
BBIO
BridgeBio Pharma, Inc.
- Health Care
- Listed 2019
- 1 day
- +1.0%
- 1 month
- +6.3%
- 1 year
- +84.8%
$82.80 · Mkt cap $16.2B
At the 6 Aug 2026 close
Nasdaq
BridgeBio Pharma, Inc.
$82.80 · Mkt cap $16.2B
At the 6 Aug 2026 close
BridgeBio Pharma, Inc. trades under the ticker BBIO on Nasdaq, in the Health Care sector (Biotechnology: Pharmaceutical Preparations). It has been listed since 2019. Its market capitalisation is $16.2B. The last closing price was $82.80, on 6 Aug 2026. No price-to-earnings ratio is shown, because it did not report positive earnings in its last annual filing. Over the past year the share price is +84.8%, and +6.3% over the past month. Returns are price returns and exclude dividends.
This page exists because BBIO is one of the shares What A Share can show you. It is not a recommendation, and its appearance here says nothing about whether the company is worth owning.